| Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 T Sekine, A Perez-Potti, O Rivera-Ballesteros, K Strålin, JB Gorin, ... Cell 183 (1), 158-168. e14, 2020 | 1995 | 2020 |
| Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function H Schlums, F Cichocki, B Tesi, J Theorell, V Beziat, TD Holmes, H Han, ... Immunity 42 (3), 443-456, 2015 | 777 | 2015 |
| Prospects for the use of NK cells in immunotherapy of human cancer HG Ljunggren, KJ Malmberg Nature Reviews Immunology 7 (5), 329-339, 2007 | 693 | 2007 |
| NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs V Béziat, LL Liu, JA Malmberg, MA Ivarsson, E Sohlberg, AT Björklund, ... Blood, The Journal of the American Society of Hematology 121 (14), 2678-2688, 2013 | 555 | 2013 |
| Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus NK Björkström, T Lindgren, M Stoltz, C Fauriat, M Braun, M Evander, ... Journal of Experimental Medicine 208 (1), 13-21, 2011 | 545 | 2011 |
| Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education NK Björkström, P Riese, F Heuts, S Andersson, C Fauriat, MA Ivarsson, ... Blood, The Journal of the American Society of Hematology 116 (19), 3853-3864, 2010 | 435 | 2010 |
| Expression patterns of NKG2A, KIR, and CD57 define a process of CD56 (dim) NK-cell differentiation uncoupled from NK-cell education NK Bjorkstrom, P Riese, F Heuts, S Andersson, C Fauriat, MA Ivarsson, ... Blood 116 (19), 3853-3864, 2010 | 432 | 2010 |
| Natural killer cell immunotypes related to COVID-19 disease severity C Maucourant, I Filipovic, A Ponzetta, S Aleman, M Cornillet, L Hertwig, ... Science immunology 5 (50), eabd6832, 2020 | 431 | 2020 |
| Education of human natural killer cells by activating killer cell immunoglobulin-like receptors C Fauriat, MA Ivarsson, HG Ljunggren, KJ Malmberg, J Michaëlsson Blood, The Journal of the American Society of Hematology 115 (6), 1166-1174, 2010 | 348 | 2010 |
| CD56bright NK cells exhibit potent antitumor responses following IL-15 priming JA Wagner, M Rosario, R Romee, MM Berrien-Elliott, SE Schneider, ... The Journal of clinical investigation 127 (11), 4042-4058, 2017 | 347 | 2017 |
| CMV drives clonal expansion of NKG2C+ NK cells expressing self‐specific KIRs in chronic hepatitis patients V Béziat, O Dalgard, T Asselah, P Halfon, P Bedossa, A Boudifa, ... European journal of immunology 42 (2), 447-457, 2012 | 327 | 2012 |
| DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells M Carlsten, NK Björkström, H Norell, Y Bryceson, T van Hall, ... Cancer research 67 (3), 1317-1325, 2007 | 322 | 2007 |
| Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells M Carlsten, H Norell, YT Bryceson, I Poschke, K Schedvins, ... The Journal of Immunology 183 (8), 4921-4930, 2009 | 311 | 2009 |
| Natural killer cell-mediated immunosurveillance of human cancer KJ Malmberg, M Carlsten, A Björklund, E Sohlberg, YT Bryceson, ... Seminars in immunology 31, 20-29, 2017 | 283 | 2017 |
| IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism KJ Malmberg, V Levitsky, H Norell, CT De Matos, M Carlsten, K Schedvins, ... The Journal of clinical investigation 110 (10), 1515-1523, 2002 | 260 | 2002 |
| Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas Y Rongcun, F Salazar-Onfray, J Charo, KJ Malmberg, K Evrin, H Maes, ... The Journal of Immunology 163 (2), 1037-1044, 1999 | 249 | 1999 |
| Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease JM Munneke, AT Björklund, JM Mjösberg, K Garming-Legert, JH Bernink, ... Blood, The Journal of the American Society of Hematology 124 (5), 812-821, 2014 | 246 | 2014 |
| Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans LL Liu, J Landskron, EH Ask, M Enqvist, E Sohlberg, JA Traherne, ... Cell reports 15 (5), 1088-1099, 2016 | 242 | 2016 |
| Metabolic reprograming via deletion of CISH in human iPSC-derived NK cells promotes in vivo persistence and enhances anti-tumor activity H Zhu, RH Blum, D Bernareggi, EH Ask, Z Wu, HJ Hoel, Z Meng, C Wu, ... Cell Stem Cell 27 (2), 224-237. e6, 2020 | 238 | 2020 |
| Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape? KJ Malmberg Cancer Immunology, Immunotherapy 53, 879-892, 2004 | 232 | 2004 |
Niklas K BjörkströmProfessor, Karolinska InstitutetEmail verificata su ki.se
